These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24643519)

  • 1. Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.
    Maasz G; Pirger Z; Reglodi D; Petrovics D; Schmidt J; Kiss P; Rivnyak A; Hashimoto H; Avar P; Jambor E; Tamas A; Gaszner B; Mark L
    J Mol Neurosci; 2014 Nov; 54(3):310-9. PubMed ID: 24643519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes.
    Reglodi D; Jungling A; Longuespée R; Kriegsmann J; Casadonte R; Kriegsmann M; Juhasz T; Bardosi S; Tamas A; Fulop BD; Kovacs K; Nagy Z; Sparks J; Miseta A; Mazzucchelli G; Hashimoto H; Bardosi A
    J Pathol; 2018 Aug; 245(4):478-490. PubMed ID: 29774542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor 1 (PAC1) in the human infant brain and changes in the Sudden Infant Death Syndrome (SIDS).
    Huang J; Waters KA; Machaalani R
    Neurobiol Dis; 2017 Jul; 103():70-77. PubMed ID: 28392470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
    J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice.
    Hashimoto H; Shintani N; Baba A
    Ann N Y Acad Sci; 2006 Jul; 1070():75-89. PubMed ID: 16888150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of rat hypothalamus, hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP.
    Gasperini L; Piubelli C; Carboni L
    Mol Biol Rep; 2012 Mar; 39(3):2921-35. PubMed ID: 21687973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and morphometric comparison of the molar teeth in pre-eruptive developmental stage of PACAP-deficient and wild-type mice.
    Sandor B; Fintor K; Felszeghy S; Juhasz T; Reglodi D; Mark L; Kiss P; Jungling A; Fulop BD; Nagy AD; Hashimoto H; Zakany R; Nagy A; Tamas A
    J Mol Neurosci; 2014 Nov; 54(3):331-41. PubMed ID: 25112419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
    Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
    Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice.
    Hori M; Nakamachi T; Rakwal R; Shibato J; Ogawa T; Aiuchi T; Tsuruyama T; Tamaki K; Shioda S
    J Neuroinflammation; 2012 Nov; 9():256. PubMed ID: 23176072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.
    Tamas A; Szabadfi K; Nemeth A; Fulop B; Kiss P; Atlasz T; Gabriel R; Hashimoto H; Baba A; Shintani N; Helyes Z; Reglodi D
    Neurotox Res; 2012 May; 21(4):435-44. PubMed ID: 22203609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP is an endogenous protective factor-insights from PACAP-deficient mice.
    Reglodi D; Kiss P; Szabadfi K; Atlasz T; Gabriel R; Horvath G; Szakaly P; Sandor B; Lubics A; Laszlo E; Farkas J; Matkovits A; Brubel R; Hashimoto H; Ferencz A; Vincze A; Helyes Z; Welke L; Lakatos A; Tamas A
    J Mol Neurosci; 2012 Nov; 48(3):482-92. PubMed ID: 22528455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.
    Brubel R; Kiss P; Vincze A; Varga A; Varnagy A; Bodis J; Mark L; Jambor E; Maasz G; Hashimoto H; Helyes Z; Toth G; Tamas A; Koppan M; Reglodi D
    J Mol Neurosci; 2012 Nov; 48(3):623-30. PubMed ID: 22638857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous pituitary adenylate cyclase activating polypeptide (PACAP) in myelination of the rodent brain: lessons from PACAP-deficient mice.
    Vincze A; Reglodi D; Helyes Z; Hashimoto H; Shintani N; Abrahám H
    Int J Dev Neurosci; 2011 Dec; 29(8):923-35. PubMed ID: 21726625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Notch Signaling in Developing Molar Teeth of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Deficient Mice.
    Fulop BD; Sandor B; Szentleleky E; Karanyicz E; Reglodi D; Gaszner B; Zakany R; Hashimoto H; Juhasz T; Tamas A
    J Mol Neurosci; 2019 Jul; 68(3):377-388. PubMed ID: 30094580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
    Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
    Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
    Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
    Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intestinal cold preservation injury on pituitary adenylate cyclase-activating polypeptide in knockout and wild-type mice.
    Ferencz A; Nedvig K; Fekecs T; Rácz B; Wéber G; Hashimoto H; Baba A; Helyes Z; Reglödi D
    Transplant Proc; 2010; 42(6):2290-2. PubMed ID: 20692465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP Protects the Adolescent and Adult Mice Brain from Ethanol Toxicity and Modulates Distinct Sets of Genes Regulating Similar Networks.
    Lacaille H; Duterte-Boucher D; Vaudry H; Zerdoumi Y; Flaman JM; Hashimoto H; Vaudry D
    Mol Neurobiol; 2017 Nov; 54(9):7534-7548. PubMed ID: 27826748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.